Adaptive Biotechnologies
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Adaptive Biotechnologies's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8% to $170,276,000. Profit margin reached -132%. Total operating expenses were $321,758,000.

Profit Margin

Adaptive Biotechnologies Corporation (NASDAQ:ADPT): Profit margin
2017 38.44M -42.83M -111.4%
2018 55.66M -46.44M -83.44%
2019 85.07M -58.82M -69.14%
2020 98.38M -139.63M -141.93%
2021 154.34M -205.61M -133.22%
2022 185.30M -142.46M -76.88%
2023 170.27M -225.25M -132.29%

ADPT Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
170.27M185.30M154.34M98.38M85.07M55.66M38.44M
Cost of revenue
75.55M57.90M49.30M22.53M22.27M19.66M15.68M
Gross profit
94.72M127.39M105.04M75.85M62.79M35.99M22.76M
Operating exp.
Research and development
122.11M141.75M142.34M116.07M70.70M39.15M31.99M
Selling and marketing
88.57M95.60M95.46M61.35M38.45M24.48M16.76M
Total operating expenses
321.75M327.58M314.00M228.66M141.18M85.75M66.40M
Operating income
-227.03M-200.18M-208.96M-152.81M-78.39M-49.75M-44.47M
Other income (expenses), net
1.73M-182K1.66M6.59M9.78M3.30M1.64M
Income before tax
-225.30M-200.36M-207.29M-146.22M-68.60M-46.44M-42.83M
Income tax expense
0-57.90M-1.68M-6.59M-9.78M3.30M-804K
Net income
-225.25M-142.46M-205.61M-139.63M-58.82M-46.44M-42.83M
Earnings per share
Basic EPS
-1.56-1-1.46-1.06-0.85-0.44-0.41
Diluted EPS
-1.56-1-1.46-1.06-0.85-0.44-0.41
Data sourceData sourceData sourceData sourceData source